In the May 30 Federal Register, FDA issued a final order reclassifying nucleic acid-based in vitro diagnostic ("IVD") devices for the detection of Mycobacterium tuberculosis complex in respiratory specimens from class III into class II. This rule is effective June 30.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
